Estenova aims to become a big name in medical aesthetics
The Chinese developer of anti-wrinkle fillers is seeking a cash injection from a Hong Kong share listing to bring its plumping products to the market Key Takeaways: The biotech made…
Recent Articles
RELATED ARTICLES
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK -
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
- Anti-toxin provider Jiangxi Institute joins biopharma IPO rush
- PegBio aims to bulk up its finances to deliver weight-loss drugs
-
Kintor Pharma shifts from cancer drugs to cosmetics as funds run low
9939.HK
- Zhipu in race to become first to list among new generation of Chinese ‘AI tigers’
- Cancer drug maker Genfleet joins Hong Kong IPO influx
